WHO pharmaceuticals newsletter - No. 3, 2022

Overview

The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and legal actions taken by regulatory authorities around the world. It also provides signals based on information from the WHO global database of individual case safety reports, VigiBase.
In addition, this edition includes summaries of discussions and recommendations from the first joint meeting of the WHO Global Advisory Committee on Vaccine Safety (GACVS) and the WHO Advisory Committee on Safety of Me dicinal Products (ACSoMP), 14 16 June 2022.